Healthequity Inc (HQY)

R&D to Revenue

19.99%

Fiscal year · Period ending:

HQY logo

HQY R&D to Revenue

Latest reported19.99%
HQY FY R&D/Revenue (9.18% → 19.99%)
High-resolution chart · PNG

HQY r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Healthequity Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
19.9866%
19.9632%
21.8901%
22.4399%
20.8%
17.0139%
14.5821%
12.2046%
11.9312%
12.5441%
13.2759%
11.9526%
11.5166%
9.1759%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.